Automated measurement of mouse apolipoprotein B: Convenient screening tool for mouse models of atherosclerosis

Clinical Chemistry

Volumn 43, Issue 4, 1997, Pages 669-674

  Levine, Daniel M ^a   Williams, Kevin Jon ^b  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

animal models of disease; apo E; diet, effects of; LDL receptor; lipoproteins; mice, transgenic

Indexed keywords

ANTISERUM; APOLIPOPROTEIN B; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; APOLIPOPROTEIN E;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CALIBRATION; CONTROLLED STUDY; GENOTYPE; IMMUNOASSAY; IMMUNOBLOTTING; INBRED STRAIN; LABORATORY AUTOMATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; SCREENING TEST; TURBIDIMETRY;

ANIMALIA;

EID: 0030938596     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.4.669     Document Type: Article

References (27)

1. Paigen B, Mitchell D, Reue K, Morrow A, Lusis AJ, LeBoeuf RC. Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice. Proc Natl Acad Sci U S A 1987;84:3763-7.
2. Liao F, Andalibi A, Qiao JH, Allayee H, Fogelman AM, Lusis AJ. Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice. J Clin Invest 1994;94:877-84.
3. Aleman-Gomez JA, Kumar V, Borecki I, Schonfeld G, Lange LG. Restriction fragment length polymorphism of the human pancreatic cholesterol esterase gene and its association with serum lipid levels [Abstract]. Arterioscler Thromb 1991;11:1438a.
4. Renier G, Skamene E, DeSanctis JB, Radzioch D. High macrophage lipoprotein lipase expression and secretion are associated in inbred murine strains with susceptibility to atherosclerosis. Arterioscler Thromb 1993;13:190-6.
5. Lusis AJ. Genetic factors affecting blood lipoproteins: the candidate gene approach. J Lipid Res 1988;29:397-429.
6. Reue KL, Warden CH, Lusis AJ. Animal models for genetic lipoprotein disorders. Curr Opin Lipidol 1990;1:143-50.
7. Gordon JW, Ruddle FH. Integration and stable germ line transmission of genes injected into mouse pronuclei. Science 1981;214:1244-6.
8. Palmiter RD, Brinster RL, Hammer RE, Trumbauer ME, Rosenfeld MG, Birnberg NC, Evans RM. Dramatic growth of mice that develop from eggs microinjected with metallothionein-growth hormone fusion genes. Nature 1982;300:611-5.
9. Koretsky AP. Investigation of cell physiology in the animal using transgenic technology. Am J Physiol 1992;262:C261-75.
10. Bronson SK, Smithies O. Altering mice by homologous recombination using embryonic stem cells. J Biol Chem 1994;269:27155-8.
11. Breslow JL. Mouse models of atherosclerosis. Science 1996;272:685-8.
12. Camus M-C, Chapman MJ, Forgez P, Laplaud PM. Distribution and characterization of the serum lipoproteins and apoproteins in the mouse. Mus musculus. J Lipid Res 1983;24:1210-28.
13. Kane JP, Hardman DA, Paulus HE. Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons. Proc Natl Acad Sci U S A 1980;77:2465-9.
14. Sparks CE, Marsh JB. Analysis of lipoprotein apoproteins by SDS-gel filtration column chromatography. J Lipid Res 1981;22:514-8.
15. Zilversmit DB. Atherogenesis. A postprandial phenomenon. Circulation 1979;60:473-85.
16. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis [Review]. Arterioscler Thromb Vase Biol 1995;15:551-61.
17. Maguire GF, Lee M, Connelly PW. Sodium dodecyl sulfate-glycerol polyacrylamide slab gel electrophoresis for the resolution of apolipoproteins. J Lipid Res 1989;30:757-61.
18. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W. Current protocols in immunology, Vol 1. New York: John Wiley & Sons, 1992:2.4.1-2.4.9.
19. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 1992;258:468-71.
20. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993;92:883-93.
21. Ishibashi S, Herz J, Maeda N, Goldstein JL, Brown MS. The two-receptor model of lipoprotein clearance: tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. Proc Natl Acad Sci U S A 1994;91:4431-5.
22. Markwell MAK, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 1978;87:206-10.
23. Nishina PM, Verstuyft J, Paigen B. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J Lipid Res 1990;31:859-69.
24. NCCLS. Tentative Guideline EP5-T2. User evaluation of precision performance of clinical chemistry devices. Villanova, PA: National Committee for Clinical Laboratory Standards, 1992:46 pp.
25. Poapst M, Uffelman K, Steiner G. The cnromogenicity and quantitation of apoB-100 and apoB-48 of human plasma lipoproteins on analytical SDS gel electrophoresis. Atherosclerosis 1987;65:75-88.
26. Levine DM, Sloan BJ, Donner JE, Lorenz JD, Heinzerling R. Automated measurement of Lp(a) by immunoturbidimetric analysis. Int J Clin Lab Res 1992;22:173-8.
27. Levine DM, Parker TS, Sloan BJ, Ribary E. Triglyceride interference with an immunoturbidimetric quantification of lipoprotein(a) in serum [Response to Letter]. Clin Chem 1994;40:1602-3.